GLOBUS MEDICAL, INC. (GMED) Operating Margin
- Operating margin · 12 months: Value 20.34%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 20.34% | Operating income / revenue. Period ending 2026-06-30. $639.52M ÷ $3.14B × 100 ≈ 20.34% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 639.52M USD | Operating Income (Loss) |
| Revenue | 3.14B USD | |
| Cost of products and services | 989.14M USD | Cost of Goods and Services Sold |
| Research and development | 147.06M USD | Research and Development Expense |
| Selling, general and administration | 1.22B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $639.52M | $3.14B | $989.14M | $147.06M | $1.22B | 20.34% |
| 2026-03-31 | $533.20M | $3.10B | $996.47M | $150.69M | $1.23B | 17.20% |
| 2025-12-31 | $479.82M | $2.94B | $957.80M | $147.25M | $1.18B | 16.33% |
| 2025-09-30 | $370.75M | $2.77B | $960.13M | $144.49M | $1.11B | 13.39% |
| 2025-06-30 | $281.49M | $2.63B | $978.11M | $141.80M | $1.04B | 10.72% |
| 2025-03-31 | $255.00M | $2.51B | $989.39M | $139.55M | $975.17M | 10.16% |
| 2024-12-31 | $165.99M | $2.52B | $1.04B | $163.75M | $981.05M | 6.59% |
| 2024-09-30 | $115.84M | $2.48B | $1.04B | $182.60M | $972.29M | 4.67% |
| 2024-06-30 | $68.15M | $2.24B | $902.40M | $176.55M | $887.75M | 3.05% |
| 2024-03-31 | $84.74M | $1.90B | $718.84M | $160.20M | $769.70M | 4.46% |
| 2023-12-31 | $133.14M | $1.57B | $548.17M | $124.01M | $643.41M | 8.49% |
| 2023-09-30 | $177.05M | $1.23B | $353.28M | $91.27M | $516.77M | 14.44% |
| 2023-06-30 | $236.34M | $1.10B | $283.39M | $80.64M | $467.14M | 21.55% |
| 2023-03-31 | $237.91M | $1.07B | $275.38M | $76.69M | $453.79M | 22.26% |
| 2022-12-31 | $227.95M | $1.02B | $263.73M | $73.02M | $432.12M | 22.29% |
| 2022-09-30 | $192.12M | $998.37M | $254.93M | $104.53M | $420.60M | 19.24% |
| 2022-06-30 | $185.75M | $973.94M | $247.99M | $101.68M | $410.47M | 19.07% |
| 2022-03-31 | $163.85M | $961.31M | $243.36M | $99.83M | $411.01M | 17.04% |
| 2021-12-31 | $171.95M | $958.10M | $239.22M | $97.35M | $408.15M | 17.95% |
| 2021-09-30 | $212.29M | $941.53M | $238.29M | $61.56M | $393.64M | 22.55% |
| 2021-06-30 | $208.97M | $927.90M | $236.83M | $60.13M | $386.34M | 22.52% |
| 2021-03-31 | $137.53M | $825.81M | $223.63M | $84.04M | $359.11M | 16.65% |
| 2020-12-31 | $111.43M | $789.04M | $217.46M | $84.52M | $354.76M | 14.12% |
| 2020-09-30 | $102.88M | $767.26M | $205.37M | $84.77M | $354.85M | 13.41% |
| 2020-06-30 | $94.92M | $747.38M | $193.65M | $84.86M | $354.15M | 12.70% |
| 2020-03-31 | $163.36M | $793.00M | $187.00M | $61.15M | $362.51M | 20.60% |
| 2019-12-31 | $171.99M | $785.37M | $179.97M | $60.07M | $354.76M | 21.90% |
| 2019-09-30 | $165.26M | $769.64M | $177.17M | $58.34M | $346.26M | 21.47% |
| 2019-06-30 | $161.50M | $742.66M | $169.63M | $59.35M | $332.94M | 21.75% |
| 2019-03-31 | $160.77M | $721.50M | $163.28M | $57.13M | $321.68M | 22.28% |
| 2018-12-31 | $169.32M | $712.97M | $159.41M | $55.50M | $311.59M | 23.75% |
| 2018-09-30 | $174.43M | $693.07M | (m) | $53.15M | $300.91M | 25.17% |
| 2018-06-30 | $171.93M | $675.57M | (m) | $48.51M | $289.14M | 25.45% |
| 2018-03-31 | $167.16M | $654.58M | (m) | $45.70M | $276.45M | 25.54% |
| 2017-12-31 | $161.84M | $635.98M | (m) | $43.68M | $267.82M | 25.45% |
| 2017-09-30 | $149.20M | $611.53M | (m) | $45.91M | $255.70M | 24.40% |
| 2017-06-30 | $151.06M | $595.44M | (m) | $45.29M | $246.54M | 25.37% |
| 2017-03-31 | $151.60M | $580.54M | (m) | $45.17M | $235.42M | 26.11% |
| 2016-12-31 | $154.14M | $563.99M | (m) | $44.53M | $222.16M | 27.33% |
| 2016-09-30 | $174.42M | $554.99M | (m) | $41.23M | $217.89M | 31.43% |
| 2016-06-30 | $177.44M | $556.33M | (m) | $40.70M | $214.20M | 31.89% |
| 2016-03-31 | $176.55M | $552.41M | (m) | $38.52M | $216.29M | 31.96% |
| 2015-12-31 | $172.22M | $544.75M | (m) | $36.98M | $214.01M | 31.61% |
| 2015-09-30 | $155.87M | $530.97M | (m) | $35.55M | $208.33M | 29.36% |
| 2015-06-30 | $150.12M | $511.76M | (m) | $34.29M | $201.49M | 29.33% |
| 2015-03-31 | $144.64M | $491.76M | (m) | $32.90M | $193.41M | 29.41% |
| 2014-12-31 | $138.36M | $474.37M | (m) | $31.69M | $187.80M | 29.17% |
| 2014-09-30 | $130.47M | $460.81M | (m) | $29.70M | $185.76M | 28.31% |
| 2014-06-30 | $125.05M | $450.21M | (m) | $28.12M | $184.47M | 27.77% |
| 2014-03-31 | $104.68M | $443.65M | (m) | $27.47M | $183.80M | 23.60% |
| 2013-12-31 | $101.67M | $434.46M | (m) | $26.87M | $182.52M | 23.40% |
| 2013-09-30 | $99.04M | $419.75M | (m) | $27.68M | $181.47M | 23.59% |
| 2013-06-30 | $96.59M | $407.33M | (m) | $28.13M | $177.55M | 23.71% |
| 2013-03-31 | $115.97M | $396.30M | (m) | $28.04M | $173.03M | 29.26% |
| 2012-12-31 | $114.79M | $385.99M | (m) | $27.93M | $168.86M | 29.74% |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $347.92M | (m) | (m) | (m) | (m) |
| 2011-12-31 | $97.36M | $331.48M | (m) | $23.46M | $140.39M | 29.37% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $87.69M | $288.19M | (m) | $21.31M | $122.59M | 30.43% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |